107 related articles for article (PubMed ID: 15911215)
1. Biphasic accumulation kinetics of [99mTc]-hexakis-2-methoxyisobutyl isonitrile in tumour cells and its modulation by lipophilic P-glycoprotein ligands.
Márián T; Balkay L; Szabó G; Krasznai ZT; Hernádi Z; Galuska L; Szabó-Péli J; Esik O; Trón L; Krasznai Z
Eur J Pharm Sci; 2005 Jun; 25(2-3):201-9. PubMed ID: 15911215
[TBL] [Abstract][Full Text] [Related]
2. Effects of miltefosine on membrane permeability and accumulation of [99mTc]-hexakis-2-methoxyisobutyl isonitrile, 2-[18F]fluoro-2-deoxy-D-glucose, daunorubucin and rhodamine123 in multidrug-resistant and sensitive cells.
Márián T; Balkay L; Trón L; Krasznai ZT; Szabó-Péli J; Krasznai Z
Eur J Pharm Sci; 2005 Apr; 24(5):495-501. PubMed ID: 15784339
[TBL] [Abstract][Full Text] [Related]
3. Pgp inhibition by UIC2 antibody can be followed in vitro by using tumor-diagnostic radiotracers, 99mTc-MIBI and 18FDG.
Krasznai ZT; Tóth A; Mikecz P; Fodor Z; Szabó G; Galuska L; Hernádi Z; Goda K
Eur J Pharm Sci; 2010 Dec; 41(5):665-9. PubMed ID: 20869436
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel modifies the accumulation of tumor-diagnostic tracers in different ways in P-glycoprotein-positive and negative cancer cells.
Krasznai ZT; Péli-Szabó J; Németh E; Balkay L; Szabó G; Goda K; Galuska L; Trón L; Major T; Hernádi Z
Eur J Pharm Sci; 2006 Jun; 28(3):249-56. PubMed ID: 16574387
[TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance.
Márián T; Szabó G; Goda K; Nagy H; Szincsák N; Juhász I; Galuska L; Balkay L; Mikecz P; Trón L; Krasznai Z
Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1147-54. PubMed ID: 12830325
[TBL] [Abstract][Full Text] [Related]
6. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex.
Piwnica-Worms D; Chiu ML; Budding M; Kronauge JF; Kramer RA; Croop JM
Cancer Res; 1993 Mar; 53(5):977-84. PubMed ID: 8094997
[TBL] [Abstract][Full Text] [Related]
7. Differences between accumulation of 99mTc-MIBI and 201Tl-thallous chloride in tumour cells: role of P-glycoprotein.
Ballinger JR; Sheldon KM; Boxen I; Erlichman C; Ling V
Q J Nucl Med; 1995 Jun; 39(2):122-8. PubMed ID: 8574806
[TBL] [Abstract][Full Text] [Related]
8. Expression of recombinant human multidrug resistance P-glycoprotein in insect cells confers decreased accumulation of technetium-99m-sestamibi.
Rao VV; Chiu ML; Kronauge JF; Piwnica-Worms D
J Nucl Med; 1994 Mar; 35(3):510-5. PubMed ID: 7906729
[TBL] [Abstract][Full Text] [Related]
9. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium(I) in cultured mouse fibroblasts.
Chiu ML; Kronauge JF; Piwnica-Worms D
J Nucl Med; 1990 Oct; 31(10):1646-53. PubMed ID: 2213187
[TBL] [Abstract][Full Text] [Related]
10. Uptake of the cation hexakis(2-methoxyisobutylisonitrile)-technetium-99m by human carcinoma cell lines in vitro.
Delmon-Moingeon LI; Piwnica-Worms D; Van den Abbeele AD; Holman BL; Davison A; Jones AG
Cancer Res; 1990 Apr; 50(7):2198-202. PubMed ID: 2317808
[TBL] [Abstract][Full Text] [Related]
11. Involvement of glutathione in loss of technetium-99m-MIBI accumulation related to membrane MDR protein expression in tumor cells.
Moretti JL; Duran Cordobes M; Starzec A; de Beco V; Vergote J; Benazzouz F; Boissier B; Cohen H; Safi N; Piperno-Neumann S; Kouyoumdjian JC
J Nucl Med; 1998 Jul; 39(7):1214-8. PubMed ID: 9669397
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo tracer characteristics of an established multidrug-resistant human colon cancer cell line.
Lorke DE; Krüger M; Buchert R; Bohuslavizki KH; Clausen M; Schumacher U
J Nucl Med; 2001 Apr; 42(4):646-54. PubMed ID: 11337555
[TBL] [Abstract][Full Text] [Related]
13. Hepatic technetium Tc 99m-labeled sestamibi elimination rate and ABCB1 (MDR1) genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancer.
Wong M; Evans S; Rivory LP; Hoskins JM; Mann GJ; Farlow D; Clarke CL; Balleine RL; Gurney H
Clin Pharmacol Ther; 2005 Jan; 77(1):33-42. PubMed ID: 15637529
[TBL] [Abstract][Full Text] [Related]
14. Using 99mTc-sestamibi to evaluate the effects of a chemosensitizer on P-glycoprotein in multidrug-resistant carcinoma cells.
Zhang Z; Zhang X; Wu H; Zhao M
Methods Enzymol; 2004; 386():212-6. PubMed ID: 15120253
[No Abstract] [Full Text] [Related]
15. Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence.
Piwnica-Worms D; Kronauge JF; Chiu ML
Circulation; 1990 Nov; 82(5):1826-38. PubMed ID: 2225379
[TBL] [Abstract][Full Text] [Related]
16. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
[TBL] [Abstract][Full Text] [Related]
17. [An in-vitro study of 99mTc sestamibi uptake by normal and neoplastic cell lines].
Stefănescu C; Rusu V; Maublant JC
Rev Med Chir Soc Med Nat Iasi; 1995; 99(1-2):116-23. PubMed ID: 9524667
[TBL] [Abstract][Full Text] [Related]
18. Effects of induction of multi-drug resistance on accumulation of 99mTc-sestamibi in vitro.
Bender H; Friedrich E; Zamora PO; Guhlke S; Biersack HJ
Anticancer Res; 1997; 17(3B):1833-9. PubMed ID: 9179241
[TBL] [Abstract][Full Text] [Related]
19. [Examination of resistance of lung adenocarcinoma cells to cisplatin by technetium-99m methoxyisobutyl isonitrile].
Hu S; Hu CP; Liang CH
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1493-8. PubMed ID: 16061030
[TBL] [Abstract][Full Text] [Related]
20. Comparative 99mTc-sestamibi and 3H-daunomycin uptake in human carcinoma cells: relation to the MDR phenotype and effects of reversing agents.
Cayre A; Moins N; Finat-Duclos F; Maublant J; Verrelle P
J Nucl Med; 1999 Apr; 40(4):672-6. PubMed ID: 10210228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
